These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2650084)

  • 1. Histoincompatible skin and marrow grafts in mice given cholera toxin.
    Tsuru S; Taniguchi M; Shinomiya N; Takemura T; Togami M
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1158-60. PubMed ID: 2650084
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of cholera toxin on pancreatic islet transplantation in mice.
    Takeda Y; Satomi S; Miura S; Koja S; Morimoto K; Okamoto M; Oguma S; Taguchi Y; Mori S
    Transplant Proc; 1991 Feb; 23(1 Pt 1):873-4. PubMed ID: 1990709
    [No Abstract]   [Full Text] [Related]  

  • 3. Extended skin allo- and xenograft survival in mice treated with rapamycin, antilymphocyte serum, and donor-specific bone marrow transfusion.
    Hale DA; Gottschalk R; Fukuzaki T; Wood ML; Maki T; Monaco AP
    Transplant Proc; 1996 Dec; 28(6):3269. PubMed ID: 8962269
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of skin graft rejection in mice by rapamycin: a novel immunosuppressive macrolide.
    Eng CP; Gullo-Brown J; Chang JY; Sehgal SN
    Transplant Proc; 1991 Feb; 23(1 Pt 1):868-9. PubMed ID: 1990708
    [No Abstract]   [Full Text] [Related]  

  • 5. Specific tolerance induction of allo-K(b)-skin grafts by FK506 in the CD8-depleted H-2(k) recipients required low amounts of K(b)-antigen.
    Chen BG; Liu Z; Wu Y
    Transpl Immunol; 2005 Oct; 15(1):9-16. PubMed ID: 16223668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed type hypersensitivity (DTH) response and skin graft survival in 9-(1, 3-dihydroxy-2-propoxymethyl) guanine (DHPG) treated mice.
    Shelby J; Saffle JR; Kern ER
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1150-1. PubMed ID: 2650083
    [No Abstract]   [Full Text] [Related]  

  • 7. LF 08-0299 protects murine recipients of minor antigen disparate donor bone marrow from lethal graft-versus-host disease.
    Bruley-Rosset M; Churaqui E; Annat J; Dutartre P
    Transplant Proc; 1996 Dec; 28(6):3114-6. PubMed ID: 8962208
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevention of acute graft-versus-host disease by treatment with a novel immunosuppressant. Cholera toxin B subunit.
    Yankelevich B; Brown E; Mazumder A
    J Immunol; 1995 Apr; 154(7):3611-7. PubMed ID: 7897240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of single-dose, late treatment with rapamycin on skin allograft survival in ALS- and donor bone marrow cell-treated mice.
    De Fazio SR; Plowey J; Hartner WC; Gozzo JJ
    Transplant Proc; 1994 Dec; 26(6):3102-3. PubMed ID: 7998084
    [No Abstract]   [Full Text] [Related]  

  • 10. The immunosuppressive effect of concanvalin A. III. Influence on the survival time of skin allografts in mice.
    Wasik MR; Skopińska E; Mościcka-Wesołowska M
    Arch Immunol Ther Exp (Warsz); 1980; 28(4):635-9. PubMed ID: 7006566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of FK-506 on xenotransplantation of the heart and skin in a mouse-rat combination.
    Ochiai T; Nagata M; Nakajima K; Isono K; Inamura N; Nakahara K
    Transplant Proc; 1987 Oct; 19(5 Suppl 6):84-6. PubMed ID: 2445083
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of rapamycin on induction of unresponsiveness in ALS-treated, marrow-injected mice.
    Bobbio SA; Wood ML; Monaco AP
    Transplant Proc; 1993 Feb; 25(1 Pt 1):717-8. PubMed ID: 8438453
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug-induced tolerance to allografts in mice. III. Prolongation of skin graft survival by tolerance induction in congenic mice disparate in the major H-2 antigens.
    Shin T; Himeno K; Mayumi H; Nomoto K
    Transplantation; 1985 Mar; 39(3):333-5. PubMed ID: 3883602
    [No Abstract]   [Full Text] [Related]  

  • 14. Requirement of a higher degree of chimerism for skin allograft tolerance in cyclophosphamide-induced tolerance.
    Iwai T; Tomita Y; Zhang QW; Shimizu I; Nomoto K; Yasui H
    Transpl Int; 2005 May; 17(12):795-803. PubMed ID: 15856178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skin transplantation in mice and dogs. Effect of cyclosporin A and dihydrocyclosporin C.
    Borel JF; Meszaros J
    Transplantation; 1980 Feb; 29(2):161-2. PubMed ID: 6986689
    [No Abstract]   [Full Text] [Related]  

  • 16. Specific immune suppression in adult mice across K-I-D fully allogeneic histoincompatibility barriers induced by lymphocyte-free bone marrow cells.
    Müller-Ruchholtz W; Blank M; Wottge HU; Müller-Hermelink HK
    Transplant Proc; 1981 Mar; 13(1 Pt 1):603-7. PubMed ID: 7022898
    [No Abstract]   [Full Text] [Related]  

  • 17. Prolongation of allograft survival by cyclosporin A.
    Cosimi AB; Shield CF; Peters C; Burton RC; Scott G; Russell PS
    Surg Forum; 1979; 30():287-9. PubMed ID: 120019
    [No Abstract]   [Full Text] [Related]  

  • 18. The necessity of both allogeneic antigens and stem cells for cyclophosphamide-induced skin allograft tolerance in mice.
    Mayumi H; Good RA
    Transplant Proc; 1988 Feb; 20(1 Suppl 1):139-41. PubMed ID: 2894728
    [No Abstract]   [Full Text] [Related]  

  • 19. Cyclosporin-A-induced long-term survival of fully incompatible skin and heart grafts in rats.
    White DJ; Rolles K; Ottawa T; Turell O
    Transplant Proc; 1980 Jun; 12(2):261-5. PubMed ID: 6994294
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative study of toxicity and efficacy of cyclosporine, cyclosporine G (OG37), FK 506, and rapamycin in BALB/c mice with fitted skin grafts.
    Masri MA
    Transplant Proc; 1995 Feb; 27(1):366. PubMed ID: 7533412
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.